A massive data dump this morning and over the weekend from biotech firms reporting results from various drug trials and regulatory updates. Stocks on the move as a result: Cell Therapeutics (CTICD, press release) +2.8%, Exelixis (EXEL, PR) -2.2%, Incyte (INCY, PR) +3%, Corcept Therapeutics (CORT, PR) -4.8%, United Therapeutics (UTHR, PR) -6.1%, RXi Pharmaceuticals (RXII, PR) +17.7%, Impax Labs (IPXL, PR) -3.3%.
A massive data dump this morning and over the weekend from biotech firms reporting results from...
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs